Bank of America’s Medicus Sciences Acquisition Corp. Class A Ordinary Share MSAC Stock Holding History

Bank of America’s Portfolio MSAC Stock Details MSAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-260,000	Closed	-$2.62M	–	8607
2022 Q4	$2.62M	Hold	260,000	–	–	﹤0.01%	4017
2022 Q3	$2.57M	Hold	260,000	–	–	﹤0.01%	4050
2022 Q2	$2.54M	Hold	260,000	–	–	﹤0.01%	4082
2022 Q1	$2.54M	Buy	+260,000	New	+$2.53M	﹤0.01%	4354

Bank of America's MSAC Position: Q1 2023 in Review

Bank of America sold out of Medicus Sciences Acquisition Corp. Class A Ordinary Share (MSAC) in Q1 2023, closing a stake of 260,000 shares — an estimated $2.62M sold.

Bank of America first reported a position in MSAC in Q1 2022 and held it in 4 quarters. The position peaked at $2.62M in Q4 2022. 0 funds tracked by Wall St. Rank hold MSAC as of Q1 2023.

Bank of America reported no remaining Medicus Sciences Acquisition Corp. Class A Ordinary Share position as of Q1 2023 after selling out during the quarter.
Bank of America sold 260,000 Medicus Sciences Acquisition Corp. Class A Ordinary Share shares in Q1 2023, an estimated $2.62M.
Bank of America first reported a position in Medicus Sciences Acquisition Corp. Class A Ordinary Share in Q1 2022 and held it in 4 quarters.
Bank of America's Medicus Sciences Acquisition Corp. Class A Ordinary Share position peaked at $2.62M in Q4 2022.
0 funds tracked by Wall St. Rank held Medicus Sciences Acquisition Corp. Class A Ordinary Share as of Q1 2023.

Based on Bank of America's 13F filing for Q1 2023, filed 12 May 2023.